BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1642683)

  • 1. Osteopenia in rats with drug-induced mucopolysaccharidosis.
    Lüllmann-Rauch R; Peters A; Schleicher A
    Arzneimittelforschung; 1992 Apr; 42(4):559-66. PubMed ID: 1642683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis-like cellular alterations in chondrocytes of rats treated with tilorone.
    Lüllmann-Rauch R; Michel G; Peters A
    Exp Mol Pathol; 1988 Oct; 49(2):279-89. PubMed ID: 3139444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis (MPS) in ocular tissues as induced by amphiphilic di-cationic drugs.
    Lüllmann-Rauch R
    Lens Eye Toxic Res; 1990; 7(3-4):263-79. PubMed ID: 2129218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis and lipidosis in rats treated with tilorone analogues.
    Hein L; Lüllmann-Rauch R
    Toxicology; 1989 Oct; 58(2):145-54. PubMed ID: 2508267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tilorone-induced lysosomal storage mimicking the features of mucopolysaccharidosis and of lipidosis in rat liver.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(3):355-68. PubMed ID: 6198800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucopolysaccharidosis-like alterations in cardiac valves of rats treated with tilorone.
    Horstmann G; Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(1):33-45. PubMed ID: 2580388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI.
    Nuttall JD; Brumfield LK; Fazzalari NL; Hopwood JJ; Byers S
    Calcif Tissue Int; 1999 Jul; 65(1):47-52. PubMed ID: 10369733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular basis of inflammation-induced osteopenia in growing rats.
    Krempien B; Vukicević S; Vogel M; Stavljenić A; Büchele R
    J Bone Miner Res; 1988 Oct; 3(5):573-82. PubMed ID: 3195368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultured corneal fibroblasts as a model system for the demonstration of drug-induced mucopolysaccharidosis.
    Burmester J; Handrock K; Lüllmann-Rauch R
    Arch Toxicol; 1990; 64(4):291-8. PubMed ID: 2117432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimalarials quinacrine and chloroquine induce weak lysosomal storage of sulphated glycosaminoglycans in cell culture and in vivo.
    Lüllmann-Rauch R; Pods R; von Witzendorff B
    Toxicology; 1996 Jun; 110(1-3):27-37. PubMed ID: 8658557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acridine Orange, a precipitant for sulfated glycosaminoglycans, causes mucopolysaccharidosis in cultured fibroblasts.
    Lüllmann-Rauch R; Ziegenhagen M
    Histochemistry; 1991; 95(3):263-8. PubMed ID: 1904847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tilorone-induced mucopolysaccharidosis in rats. Biochemical investigations.
    Prokopek M
    Biochem Pharmacol; 1991 Nov; 42(11):2187-91. PubMed ID: 1720315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mucopolysaccharidosis in rats by treatment with immunostimulatory acridine derivatives.
    Grave S; Lüllmann H; Lüllmann-Rauch R; Osterkamp G; Prokopek M
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):215-24. PubMed ID: 1609413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratopathy in rats after treatment with tilorone.
    Lüllmann-Rauch R
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(4):377-83. PubMed ID: 3710194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats.
    Gunness M; Orwoll E
    J Bone Miner Res; 1995 Nov; 10(11):1735-44. PubMed ID: 8592951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F; Lang K; Dony C; Kling L
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia.
    Hadjidakis D; Lempert UG; Minne HW; Ziegler R
    Horm Metab Res; 1993 Feb; 25(2):77-81. PubMed ID: 8458612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-escin on histomorphometrical parameters of long bones in rats with experimental post-steroid osteopenia.
    Cegieła U; Pytlik M; Janiec W
    Pol J Pharmacol; 2000; 52(1):33-7. PubMed ID: 10949118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ; Yen CF; Qi H; Dann LM
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tibolone on the development of osteopenia induced by ovariectomy in rats.
    Pytlik M
    Pol J Pharmacol; 2002; 54(1):35-43. PubMed ID: 12020042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.